COVID and Emerging Diseases Funding

Due to the rapidly evolving pandemic funding opportunities will be added as they are received.  Monitor this page frequently for updates.

Last updated August 12, 2020

COVID-19 FUNDING OPPORTUNITIES
SPONSOR PROGRAM FUNDING DEADLINE
Agency for Healthcare Research & Quality (AHRQ) Novel, High-Impact Studies Evaluating Health System & Healthcare Professional Responsiveness to COVID-19 (RFA-HS-20-003) $1,000,000 6/15/2020
 Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants & Cooperative Agreements to Evaluate Health System & Healthcare Professional Responsiveness to COVID-19 (PA-20-072) Budget depends on mechanism type (see RFA) LOI 5/29/2020
 Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants & Cooperative Agreements to Evaluate Health system & Healthcare Professional Responsiveness to COVID-19 (PA-20-70) Budget depends on mechanism type (see RFA) LOI 5/29/2020
 New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (NOT-HS-20-008) R01 equivalent expected June 2020
Amazon Web Services (AWS)  AWS Diagnostic Development Initiative (DDI) budget must reflect needs (up to $20M available) 6/30/2020
American diabetes Association (ADA) The American Diabetes Association COVID-19 and Diabetes Research Award $100,000 5/22/2020
American Heart Association Rapid Response Grant COVID-19 and Its Cardiovascular Impact $100,000
(coordinating center $150,000)
4/6/2020
American Lung Association  COVID-19 and Emerging Respiratory Viruses Research Award $200,000 5/30/2020
AXA Research Fund Exceptional Flash Call for Proposals: Mitigating risk in the wake of the COVID-19 Pandemic £250,000 5/1/2020
Biomedical Advanced Research & Development Authority (BARDA) BARDA Broad Agency Announcement negotiated after white paper submission 10/31/2020
Booz Allen Foundation  Booz Allen Foundation Innovation Grant $100,000 6/5/2020
Centers for Disease Control (CDC)

 

NEW callout Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States (RFA-IP-21-005)

$2,150,000

1/8/2021

Strengthening Public Health Systems & Services through National Partnerships to Improve & Protect the Nation's Health

$3,000,000

3/20/2020
(anticipated)

Applied Research Address the Coronavirus (COVID-19) Emerging Public Health Emergency

  3/25/2020
(call for white papers)
Coalition of Epidemic Preparedness Innovations (CEPI)

COVID-19 Vaccine Development & Production

unspecified accepted through 6/30/2020
COVID-19 Early Treatment Fund (CEFT)

NEW callout Funding for Outpatient Trials

up to $1,000,000 currently accepting applications

 Department of Defense (DoD)

Newton Award for Transformative Ideas during the COVID-19 Pandemic (BRO-20-Newton)

$100,000 5/15/2020

XTech COVID-19 Ventilator Challenge

White Paper $5,000
Application $100,000
4/5/2020 - 5/31/2020

Request for Information for PPE in response to COVID-19

N/A 3/24/2020
(information accepted on a rolling basis)

Prototype Development to Combat Novel Coronavirus Disease COVID-19

TBD 4/15/2020
Department of Energy (DOE)

Soliciting input to COVID-19 response

DOE Resources Rolling
Department of State 

 COVID-19 Small Grants Program Mission to India (ND-NOFO-20-111)

$100,000 9/30/2020

 US Embassy Abuja COVID 19 Response (DOS-NGA-PD-ABV-FY20-005)

$50,000 May 1,2020
Disability Inclusion Fund

 COVID-19 Rapid Response Fund

$15,000 5/6/2020
Emergency Medicine Foundation (EMF)

NEW callout Fujifilm SonoSite COVID-19 Point of Care Ultrasound Acceleration Research Grant

up to $90,000 8/21/2020
Encephalitis Society

NEW callout Encephalitis & COVID-19 Seed Funding

£10,000 8/31/2020
Environmental Protection Agency (EPA)

 Removal Emergency Response Program (EPA-OLEM-19-08)

$500,000
(5% cost share required) 
6/10/2020
Ferring Pharmaceuticals

Ferring COVID-19 Investigational Grants

€25,000 4/15/2020 (accepted through 10/31/2020)
Genentech

NEW callout 2020 Health Equity Innovations Fund

$750,000 LOI: 8/10/2020
Full invited app: 10/15/2020
Gilead

NEW callout COVID-19 RFP Program: COMMIT

$250,000 ends 8/3/2020
Harrington Discovery Institute

Harrington Scholar Award for Coronavirus

$150,000 4/30/2020
IBM XPRIZE

 2020 COVID-19 Call for Code Global Challenge

$270,000 7/31/2020
Indo-US Science & Technology Forum (IUSSTF)

Indo-US Virtual Networks for COVID-19

$66,000 5/15/2020
Internet Society Foundation

Emergency Response Grant Programme: COVID-19

$500,000 5/17/2020
IBSA Foundation for Scientific Research

NEW callout The IBSA Foundation Fellowships

€30,000 12/31/2020
LifeArc

Coronavirus therapeutics: Call for Rapid Deployment for the development and testing of therapeutics to treat COVID-19

 £10,000,000  4/6/2020
Johnson & Johnson Innovation - JLABS

DR-TB Lifeline Design Quickfire Challenge

$50,000 5/19/2020
Medical CBRN Defense Consortium (MCDC)

Prototype Development to Combat Coronavirus (COVID-19)

undetermined pre-announcement

RFI CoV Pandemic Response

undetermined

3/19/2020-5/21/2020

(call for rapid response white papers)

Leveraging STRIDES for Cloud Computing Activities in Common Fund Awards (NOT-RM-20-009) Cloud Computing support >$10,000 beginning 4/1/2020
Merck KGaA (Germany)  Research Grant for Pandemic Preparedness £1,500,000 rolling basis
Mozilla COVID-19 Solutions Fund $50,000 rolling basis
 National Institutes of Health    NOSI: Select Research Areas for Severe Acute Respiratory Syndrome 2 and Coronavirus Disease 2019 (NOT-AI-20-051) varies 6/16/2020-9/7/2021
Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System (NOT-NS-20-051) $200,000 rolling thru 4/14/2021
NOSI: Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-120) no more than $700,000 7/8/2020 - 9/20/2020
NOSI: Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-121) no more than $3,500,000 8/7/2020
NOSI: Administrative Supplements & Urgent Competitive Revisions for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-012) $150,000  5/22/2020-8/17/2020 (NCCIH grants)
NOSI: Administrative supplements to Existing NIH ECHO cooperative Agreements for COVID-19 related research (NOT-OD-20-107) $200,000 6/22/2020
NOSI: Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & COVID-19 (NOT-RM-20-015) may not exceed parent award through 6/19/2020
NOSI: Emergency Competitive Revisions on COVID-19 for Currently Active NHLBI Phase I-III Clinical Trials (NOT-HL-20-782) up to 2 years support through 10/5/2020
RFI: Strategy for Research in Coronavirus Serology Testing & Serological Sciences (NOT-CA-20-065) NCI RFI 5/26/2020
NIH Tech Accelerator Challenge 2020 $500,000 (top prize) 6/2/2020
Novel, High-Impact Studies Evaluating Health system & Healthcare Professional Responsiveness to COVID-19 (R01) (RFA-HS-20-003) $1,000,000 6/15/2020
NOSI: Data Driven Research on Coronavirus Disease 2019 (R21) (NOT-LM-20-011) $275,000 6/16/2020
Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System (NOT-NS-20-051) $200,000 until 4/14/2021
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 & COVID-19 (R21) (PAR-20-177) $275,000 until 4/30/2021
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 & COVID-19 (R01) (PAR-20-178) budget must reflect need until 4/30/2021
NOSI: Urgent Competitive Revisions & Administrative Supplements for Coronavirus disease 2019 (NOT-DE-20-22) may not exceed $150,000 6/1/2020, 11/2/2020
Rapid Acceleration of Diagnostics (RADx) up to $500,000,000 Rolling
NOSI: Administrative Supplements & Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral & Social Sciences(NOT-OD-20-097) $200,000 4/13/2020 - 3/31/2021
NOSI: NCI Urgent Competitive Revision & Administrative Supplements on Coronavirus Disease (NOT-CA-20-042) $100,000 4/14/2020 - 6/26/2020
NIEHS Worker Training Program Coronavirus & Infectious Disease Response Training (NOT-ES-20-017) $200,000 4/24/2020
NOSI: Competitive & Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health & Health Disparities (NOT-ES-20-019) $125,000 5/1/2020 - 5/1/2021
NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (NOT-ES-20-020) must reflect need 5/1/2020, 6/1/2020, (other deadlines...)
NOSI: Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 (NOT-GM-20-027) one year; no greater than current parent award 5/5/2020
 NOSI: Administrative Supplements & Competitive Revision Supplements on Coronavirus Disease 2019 (NOT-AA-20-011)  $200,000 within mission of NIAAA 5/15/2020 - 4/15/2021 
NOSI: Emergency Competitive Revisions to Existing NIH Grants & Cooperative Agreements for Tissue chips Research on the 2019 Novel Coronavirus (NOT-TR-20-017) limited to amount of current parent award 5/15/2020 - 1/25/2022
NOSI: Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-016) no more than 25% of total costs of current award 5/15/2020 - 1/25/2022
NOSI: Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (NOT-DC-20-004) $125,000 6/1/2020
NOSI: Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (NOT-DK-20-018) limited to current year budget within mission of NIDDK 6/1/2020
NOSI: Urgent Competitive Revision Supplements on Coronavirus Disease 2019 Related to HIV Comorbidities, Coinfections, and Complications (NOT-DK-20-020) limited to current year budget within mission of NIDDK 6/1/2020
NOSI: Administrative Supplements for Research on Coronavirus Disease 2019 (NOT-LM-20-010) $75,000 6/1/2020
NOSI: Development of Biomedical Technologies for Coronavirus Disease 2019 (NOT-EB-20-007) varies, check RFA 6/5/2020, 6/16/2020
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations, R01 Clinical Trial Optional (PA-20-172) not limited, multiple institutes 10/5/2020 (and standard R01 deadlines)
NOSI: Emergency Competitive Revision & Supplements on Biomedical Technologies for Coronavirus Disease 2019 (NOT-EB-20-008)  up to amount of current award rolling, ends 11/10/2020 
 NOSI: Availability of Administrative Supplements and Urgent Competitive Revision for Mental Health Research Monte 2019 Novel Coronavirus (NOT-MH-20-047) contact program officer(s) rolling basis through 4/15/2021
Urgent Competitive Revision to Existing NIH Grants & Cooperative Agreements (Urgent Supplement-Clinical Trial Optional)(PA-18-935) must reflect needs (multiple institutes) Varies by awarding IC
NOSI: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease (COVID-19) (NOT-AI-20-31) Check RFA(s) 4/5/2020 (deadlines through 4/5/2021)
NOSI: NIA Availability of Administrative Supplements & Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-AG-20-022) must reflect needs 4/6/2020 (applications accepted through 5/1/2021)
NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (NOT-TR-20-012) Applications to:
PAR-17-465
PAR-18-462
PAR-18-332
 
6/5/2020 (& other later deadlines)
Partnerships for Countermeasures against Select Pathogens (R01)(RFA-AI-20-028) $4,050,000 6/29/2020
Clinical Trials not Allowed
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement-Clinical Trial Optional) (pa-20-135) Not limited See notice of special interest by IC
NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB
Administrative Supplement NIAID no limit 2/6/2020
(applications accepted through 2/6/2021)
NOSI Regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025) not greater than parent award and reflective of actual need 3/5/2020
(applications accepted through 2/5/2021)
Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21) (PAR-18-781) $275,000 9/9/2020
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047) no limit 3/19/2020-3/31/2020
Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCOV)(NOT-AI-20-30) No limit 2/6/2021
(rolling basis)
NOSI: Availability of Administrative Supplements & Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757) not specified 3/17/2020 - 10/5/2020
(rolling basis)
Administrative Supplements to existing NIH Grants & Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) No limit Differs - check with Institutes/Centers
Partnerships for Countermeasures Against Select Pathogens (R01 Clinical Trials not Allowed) $3,750,000 6/29/2020
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) No limit 5/13/2020, 9/13/2020, see RFA for additional deadlines
National Science Foundation (NSF)  RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 check with program officers for eligibility
Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)  $200,000 (RAPID) & supplemental funding requests check with program officers for eligibility
Office of Management & Budget (OMB) Administrative Relief for Recipients & Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (M-20-17) unspecified effective immediately
Patient-Centered Outcomes Research Institute (PCORI) Phased Large Awards for Comparative Effectiveness Research - Cycle 3 2020 >$10,000,000 LOI: 9/29/2020
Full apps: 1/12/2021
Eugene Washington PCORI Engagement Award Special Cycle: Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19 $150,000 5/22/2020
COVID-19 Targeted PFA $500,000 5/26/2020
COVID-19 Related Enhancements to Existing PCORI-Funded Research Projects $500,000 rolling basis
COVID-19 Related Enhancements to Existing PCORI-Funded Engagement Awards $150,000 rolling basis
PCORI New Research Studies, Implementation and Engagement Projects COVID-19 commitment $60,000,000 just released
Pfizer Vaccine Preventable Diseases - COVID-19 Competitive Grant Program $50,000-$250,000 6/17/2020
COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program  $250,000 5/21/2020 
 COVID-19 Competitive Grant Program  $250,000 5/22/2020 
Robert Wood Johnson Foundation Emergency Response for the Health Care System: Innovation Challenge $1,000-$25,000 Phase 1: 6/12/2020
Phase 2: 8/18/2020
NEW callout  Systems for Action: supplemental Research on COVID-19 Response & Recovery up to $100,000 8/5/2020
Emergency Response for the General Public: Innovation Challenge $1,000-$25,000 Phase 1: 6/12/2020
Phase 2: 8/18/2020
Pioneering Ideas: Exploring the Future to Build a Culture of Health averages $315,000 Open
Russell Sage Foundation Social, Political, Economic, or Psychological Disruptions that Affect Social & Living Conditions in the US $175,000 5/21/2020
Society for Academic Emergency Medicine (SAEMF) SAEMF COVID-19 Research Grant $5,000-$25,000 6/1/2020
Stevens Initiative Stevens Initiative Coronavirus Response Fund $20,000 - $100,000 6/12/2020
The Rheumatology Research Foundation Scientist Development Award, Investigator Award, & Innovative Research Award varies LOI: 6/1/2020
Full: 7/1/2020
Innovative Research for Community Practitioners $400,000 LOI: 6/1/2020
Full: 8/3/2020
Twenty-three and Me 23 and Me Research Innovation Collaborations Program access to deidentified databases 6/12/2020
Tracelink  COVID-19 Relief and Support Grants $1,000,000 (available) 5/15/2020
United Nations Development Programme Centre for Technology, Innovation, & Sustainable Development  COVID-19 Detect & Protect Challenge for Solutions in Developing Countries $25,000 6/30/2020
UNMC Internal Opportunities  GP-IDeA-CTR COVID-19 risk in individuals with underlying medical conditions and Impact of the COVID-19 pandemic on palliative care practice unspecified on-going
 UNMC Nebraska Neuroscience Alliance COVID-19 Rapid Response Grants $80,000 available 5/18/2020
 College of Medicine COVID-19 Rapid Response Grants up to $100,000 5/4/2020
ViiV Healthcare  HIV & COVID-19: RFP for Research Projects to Help Improve the Understanding and Management of COVID-19 in PLHIV £250,000  5/18/2020
Wellcome Trust Epidemic Preparedness: COVID-19 Funding Call up to £2,000,000 closed to high level of interest
White House Office of Science & Technology COVID-19 High Performance Computing Consortium (Xsede) Computing Resources effective immediately
XPRIZE 2020 COVID-19 Call for Code Global Challenge $270,000 7/31/2020

Search Funding Institutional for more opportunities.